Applied Clinical Trials Direct
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
To unsubscribe or edit your member profile: Click here.
  November 3, 2011

In This Edition
News Roundup: Quintiles Acquires Outcome Sciences
Feature Interview: CER, Insights from UBC, Pfizer, Duke and Medco
Blog Posts: UN-Administered Database
Marketplace: Marketplace

Sponsored
More outreach = more study volunteers for your clinical trials.
Post your clinical trials on CenterWatch’s Clinical Trials Listing Service™ and reach a wide-ranging, highly captive patient population through our various distribution channels:

  • Targeted email messaging campaigns
  • New trial alerts to opted-in patients
  • Social media outreach
  • Collaborative partnerships
Make CenterWatch part of your patient enrollment strategy.
Email sales@centerwatch.com for information.


News Roundup
bullet Quintiles Acquires Outcome Sciences
bullet Patheon Enters $18M Diabetes Development with Boehringer Ingelheim
bullet ACR Image Metrix Formalizes Imaging Biomarker Program
bullet Almac Expands Pharma Development Facilities in UK

Feature Interview
CER and Personalized Medicine: Insights from the Experts

Blogs Posts
bullet UN-Administered Database
bullet Thoughts from CBI's Oncology Drug Development Conference
bullet A Manifesto from Rasi
bullet Merck Releases First-Ever Approved Diabetes Pill
bullet eClinical for the Rest of US
bullet The Great Debate: Can Pharma's Image Save Face?

Marketplace

Sponsored
DIA
Are You an Innovative Life Science Professional Looking to Improve Healthcare?
Register for DIA 2012 by December 31 and be Entered to Win an iPad 2!
DIA 2012 Collaborate to Innovate
June 24-28, 2012
Philadelphia, PA
www.diahome.org/DIA2012

Sponsored
PRA International
A leading global CRO, PRA is transforming clinical trials through our people, innovation and transparency. We serve our clients across all phases of drug development by providing personalized service customized to the unique requirements of each study. Our forward-thinking approach to transforming the clinical trial landscape continues to make a difference to healthcare patients around the world. www.clearlypra.com

Sponsored
Cetero Research
Cut timelines and reduce costs with Accelerated Proof-of-Concept study designs
Reduce your drug development timelines by up to 50% by combining SAD, MAD,preliminary food effect and POC studies into one multipart study. Contact Cetero at info@cetero.com or visit http://www.cetero.com/home/why-cetero/accelerated-services/first-to-proof-of-concept for more information.

Sponsored
Novella Clinical
Your goal is to give people more opportunities to enjoy life’s little moments. We promise to give you individual attention, with therapeutic and in-country expertise to help achieve your goal. See how.

 
Follow Us

Ask The Editor

Lisa Henderson
Editor in Chief
lhenderson@advanstar.com


Webcasts & Events
bullet CBI's Clinical Portals Standardization Summit, Nov. 14
bullet Interactive Response Technologies for Clinical Trials,
Nov. 14-15
bullet Clinical Trial Budgeting and Project Management, Dec. 6-7
bullet CBI's 5th Annual Alzheimer's Drug Development Summit, Dec. 12-13

People Moves

ERT, Linda Deal InVentiv Health, Mark Dmytruk Marken, Christopher O'Connell BioConvergence, Kathy Eddy CRS Group, Wolfgang Höffer, MD


You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe or edit your member profile: click here.To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.